No recent analyst price targets found for PHGUF.
Latest News for PHGUF
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
Leiden, the Netherlands, August 4, 2026: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR), today announced its participation in the Canaccord Genuity 46th Annual Growth Conference in Boston on August 12-13, 2026.
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
Pharming today announced that the U.S. FDA accepted its sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PHGUF.
Senate Trading
No Senate trades found for PHGUF.
U.S. House Trading
No House trades found for PHGUF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.